HISTORY OF CANCER HORMONOTHERAPY

N. Abduloeva, M. Scriabin, О.А. Skripko, S. K. Kaitova, R.A. Ryandjina, K. Kazakova, V. Moiseenko
{"title":"HISTORY OF CANCER HORMONOTHERAPY","authors":"N. Abduloeva, M. Scriabin, О.А. Skripko, S. K. Kaitova, R.A. Ryandjina, K. Kazakova, V. Moiseenko","doi":"10.31917/2402105","DOIUrl":null,"url":null,"abstract":"breast cancer, epidemiology, risk factors, classification, diagnosis, prognosis, marker, treatment, Lobular carcinoma in situ ((DCIS), time to progression (TTP), complete regression, partial regression, metastatic breast cancer (MBC), median progression-free survival (PFS), overall response, LH-RH agonists and antagonists, receptor estrogen, LH-releasing hormone, Gonadotropin-releasing-hormone-receptor antagonists, overall survival, prostate cancer, Castration-resistant prostate cancer (CRPC), receptor androgens, prostate-specific antigen (PSA)","PeriodicalId":101072,"journal":{"name":"Reports of Practical Oncology","volume":"7 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reports of Practical Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31917/2402105","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

breast cancer, epidemiology, risk factors, classification, diagnosis, prognosis, marker, treatment, Lobular carcinoma in situ ((DCIS), time to progression (TTP), complete regression, partial regression, metastatic breast cancer (MBC), median progression-free survival (PFS), overall response, LH-RH agonists and antagonists, receptor estrogen, LH-releasing hormone, Gonadotropin-releasing-hormone-receptor antagonists, overall survival, prostate cancer, Castration-resistant prostate cancer (CRPC), receptor androgens, prostate-specific antigen (PSA)
癌症激素治疗史
乳腺癌,流行病学,危险因素,分类,诊断,预后,标志物,治疗,小叶原位癌(DCIS),进展时间(TTP),完全消退,部分消退,转移性乳腺癌(MBC),中位无进展生存期(PFS),总反应,rh - rh激动剂和拮抗剂,受体雌激素,lh释放激素,促性腺激素释放激素受体拮抗剂,总生存,前列腺癌,去势抵抗性前列腺癌(CRPC),受体雄激素,前列腺特异性抗原
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信